Agenus Inc. (AGEN) traded within a range of $4.23 to $4.78 after opening the day at $4.6. The company has seen its stock increase in value by 6.8% so far this year. The stock was up close to 6.8% on active volume in last trading session and closed at $4.4 per share. After the recent gain, the stock is currently holding -41.26% below its 52 week high of $7.49 and 66.04% above its 12-month low of $2.65. The shares are down by over -18.06% in the last three months, and the RSI indicator value of 63.13 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the bodys immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a heat shock protein-based autologous vaccine, which has completed Phase II clinical trials for the treatment of glioblastoma; and QS-21 Stimulon, a saponin-based vaccine adjuvant that has completed Phase III clinical trials for the treatment of malaria and shingles. The companys preclinical development products include AutoSynVax, a neo-antigen based vaccine targeting the neo-epitope landscape in cancer patients; PhosphoSynVax, a vaccine candidate designed to induce immunity against a novel class of tumor specific neo-epitopes; and checkpoint modulator product candidates targeting GITR, OX40, CTLA-4, LAG-3, TIM-3, PD-1, CEACAM1, and other undisclosed targets. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
Fitbit, Inc. (FIT) managed to rebound with the stock climbing 2.27% or $0.13 to close the day at $5.86 on active trading volume of 6.41M shares, compared to its three month average trading volume of 11.12M. The San Francisco California 94105 based company has been underperforming the scientific & technical instruments group over the past 52 weeks, with the stock losing -60.67%, compared to the industry which has advanced 43.73% over the same period. With RSI of 33.26, the stock should still continue to rise and get closer to its one year target estimate of $8, making it a hold for now.
Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the users phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.
Coeur Mining, Inc. (CDE) dropped $-0.06 to close the day at a new closing price of $9.32, a -0.64% decrease in value from its previous closing price that moved the stock 201.62% above its 52 week low of $3.17. A total of 5.61M shares exchanged hands during the day compared with its three month average trading volume of 4.19M. The stock, which fluctuated between $9.2 and $9.79 during the day, currently situated -43.21% below its 52 week high. The stock is down by -18.17% in the past one month and up by 1.86% over the past three months. With a one year target estimate of $12.83 and RSI of 34.32, the stock still has upside potential, making it a hold for now.
Coeur Mining, Inc. owns, operates, explores for, and develops silver and gold properties. The company holds interests in the Palmarejo silver and gold mine located in Mexico; the Rochester silver and gold mine in northwestern Nevada; the Kensington gold mine located to the north of Juneau, Alaska; and the Wharf gold mine in South Dakota. It also owns interests in the San Bartolomé silver mine in Bolivia; the Endeavor zinc, lead, and silver mine located in Australia; the La Preciosa silver-gold exploration project in the State of Durango, Mexico; and the Joaquin silver-gold exploration project located in the Santa Cruz province of southern Argentina. Coeur Mining, Inc. markets its silver and gold concentrates to third-party refiners and smelters in the United States, China, and Japan. The company was formerly known as Coeur d’Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was founded in 1928 and is based in Chicago, Illinois.